Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease

被引:7
|
作者
Yuan, Shijin [1 ]
Pan, Yong [2 ]
Xia, Yan [1 ]
Zhang, Yan [3 ]
Chen, Jiangnan [4 ]
Zheng, Wei [5 ]
Xu, Xiaoping [6 ]
Xie, Xinyou [1 ]
Zhang, Jun [1 ]
机构
[1] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Clin Lab, Sch Med, Hangzhou 310016, Peoples R China
[2] Wenzhou Cent Hosp, Dept Clin Lab, Wenzhou 325099, Peoples R China
[3] Xixi Hosp Hangzhou, Dept Clin Lab, Hangzhou 310023, Peoples R China
[4] Shaoxing Univ, Dept Clin Lab, Affiliated Hosp, Shaoxing 312099, Peoples R China
[5] Third Peoples Hosp Yueqing, Dept Clin Lab, Wenzhou 325604, Peoples R China
[6] Jinhua Municipal Cent Hosp, Dept Clin Lab, Jinhua 321099, Zhejiang, Peoples R China
来源
关键词
Coronavirus disease-2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Duration of viral shedding; Nomogram;
D O I
10.1631/jzus.B2000608
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
With the number of cases of coronavirus disease-2019 (COVID-19) increasing rapidly, the World Health Organization (WHO) has recommended that patients with mild or moderate symptoms could be released from quarantine without nucleic acid retesting, and self-isolate in the community. This may pose a potential virus transmission risk. We aimed to develop a nomogram to predict the duration of viral shedding for individual COVID-19 patients. This retrospective multicentric study enrolled 135 patients as a training cohort and 102 patients as a validation cohort. Significant factors associated with the duration of viral shedding were identified by multivariate Cox modeling in the training cohort and combined to develop a nomogram to predict the probability of viral shedding at 9, 13, 17, and 21 d after admission. The nomogram was validated in the validation cohort and evaluated by concordance index (C-index), area under the curve (AUC), and calibration curve. A higher absolute lymphocyte count (P=0.001) and lymphocyte-to-monocyte ratio (P=0.013) were correlated with a shorter duration of viral shedding, while a longer activated partial thromboplastin time (P=0.007) prolonged the viral shedding duration. The C-indices of the nomogram were 0.732 (95% confidence interval (CI): 0.685-0.777) in the training cohort and 0.703 (95% CI: 0.642-0.764) in the validation cohort. The AUC showed a good discriminative ability (training cohort: 0.879, 0.762, 0.738, and 0.715 for 9, 13, 17, and 21 d; validation cohort: 0.855, 0.758, 0.728, and 0.706 for 9, 13, 17, and 21 d), and calibration curves were consistent between outcomes and predictions in both cohorts. A predictive nomogram for viral shedding duration based on three easily accessible factors was developed to help estimate appropriate self-isolation time for patients with mild or moderate symptoms, and to control virus transmission.
引用
收藏
页码:318 / 329
页数:12
相关论文
共 50 条
  • [31] Factors associated with prolonged duration of viral clearance in non-severe SARS-CoV-2 patients in Osaka, Japan
    Hoffman, Emma Nakagawa
    Kawachi, Haruna
    Hirayama, Atsushi
    Zhang, Jingwen
    Murayama, Ayumi
    Masui, Jun
    Fujita, Satomi
    Mori, Yasushi
    Hirayama, Takanori
    Ohara, Toshitake
    Asada, Rumiko
    Iso, Hiroyasu
    ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE, 2021, 26 (01)
  • [32] Fecal shedding of SARS-CoV-2 in COVID-19 patients: insights from animal coronaviruses
    Andre, Nicole M.
    Stout, Alison E.
    Whittaker, Gary R.
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2020, 256 (10): : 1097 - 1097
  • [33] COVID-19: The environmental implications of shedding SARS-CoV-2 in human faeces
    Quilliam, Richard S.
    Weidmann, Manfred
    Moresco, Vanessa
    Purshouse, Heather
    O'Hara, Zoe
    Oliver, David M.
    ENVIRONMENT INTERNATIONAL, 2020, 140
  • [34] Prevalence and duration of SARS-CoV-2 fecal shedding in breastfeeding dyads following maternal COVID-19 diagnosis
    Pace, Ryan M.
    King-Nakaoka, Elana A.
    Morse, Andrew G.
    Pascoe, Kelsey J.
    Winquist, Anna
    Caffe, Beatrice
    Navarrete, Alexandra D.
    Lackey, Kimberly A.
    Pace, Christina D. W.
    Fehrenkamp, Bethaney D.
    Smith, Caroline B.
    Martin, Melanie A.
    Barbosa-Leiker, Celestina
    Ley, Sylvia H.
    Mcguire, Mark A.
    Meehan, Courtney L.
    Williams, Janet E.
    Mcguire, Michelle K.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [35] Differences in Immune Response to SARS-CoV-2 in mild and severe COVID-19 Disease
    Fuhrmann, Cornelia
    INTERNIST, 2020, 61 (08): : 788 - 788
  • [36] Prolonged shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) RNA among patients with coronavirus disease 2019 (COVID-19)
    Ridgway, Jessica P.
    Shah, Nirav S.
    Robicsek, Ari A.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 (10): : 1235 - 1236
  • [37] Clinical features in coronavirus disease 2019 (COVID-19) patients with early clearance and prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA
    Zhou, Yan
    Ding, Fengming
    Bao, Wuping
    Xue, Yishu
    Han, Lei
    Zhang, Xue
    Zhang, Pengyu
    Ji, Yong
    Yin, Dongning
    Bao, Aihua
    Luo, Shan
    Xu, Zengchao
    Liu, Jun
    Zhang, Min
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [38] SARS-CoV-2 infection of kidney tissues from severe COVID-19 patients
    Radovic, Shawn
    Meng, Wen
    Chen, Luping
    Paniz Mondolfi, Alberto E.
    Bryce, Clare
    Grimes, Zachary
    Sordillo, Emilia M.
    Cordon-Cardo, Carlos
    Guo, Haitao
    Huang, Yufei
    Gao, Shou-Jiang
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (02)
  • [39] Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients
    Olea, Beatriz
    Albert, Eliseo
    Torres, Ignacio
    Amat, Paula
    Remigia, Maria Jose
    Gozalbo-Rovira, Roberto
    Rodriguez-Diaz, Jesus
    Buesa, Javier
    Luisa Blasco, Maria
    Redon, Josep
    Signes-Costa, Jaime
    Navarro, David
    JOURNAL OF CLINICAL VIROLOGY, 2021, 142
  • [40] Factors affecting antibody response to SARS-CoV-2 in patients with severe COVID-19
    Shang, Yufeng
    Liu, Tao
    Li, Jingfeng
    Wang, Xinghuan
    Zhou, Fuling
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) : 612 - 614